NCT04028219 (TRANSIT) is a clinical trial of Online surveys in Gender Incongruence, sponsored by Universitätsklinikum Hamburg-Eppendorf.

Who is sponsoring NCT04028219?

NCT04028219 is sponsored by Universitätsklinikum Hamburg-Eppendorf.

What drugs are being tested in NCT04028219?

Interventions in NCT04028219: Online surveys.

What condition does NCT04028219 study?

NCT04028219 studies Gender Incongruence.

Is NCT04028219 still recruiting?

NCT04028219 is currently recruiting now. Last updated 8 November 2022.

Last reviewed 2022-11-08 · How we verify

NCT04028219: TRANSIT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Transgender In Transition

Recruiting now Last updated 8 November 2022

What this trial tests

trial testing Online surveys in Gender Incongruence in 750 participants. Currently enrolling.

Timeline

15 May 2019

Primary endpoint
15 May 2024

15 May 2034

Quick facts

Lead sponsor	Universitätsklinikum Hamburg-Eppendorf
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	750
Start date	15 May 2019
Primary completion	15 May 2024
Estimated completion	15 May 2034
Sites	5 locations across Switzerland, Germany

Drugs / interventions tested

Online surveys

Conditions studied

Gender Incongruence — all drugs for Gender Incongruence →

Sponsor

Universitätsklinikum Hamburg-Eppendorf — full company profile →

Who can join

18 and older, any sex, with Gender Incongruence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective trial in gender dysphoric patients who undergo gender-affirming hormone therapy, aiming to investigate psychological, biological and behavioural consequences of hormonal therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Online surveys

Trials testing the same drug.

NCT03494335 — Online Surveys to Assess the Perception and Performance of Imaging and Associated Aspects · withdrawn

Other recruiting trials for Gender Incongruence

Currently open trials in the same condition.

NCT07187947 — Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway · recruiting
NCT05318755 — China Gender-affirming Hormone Therapy Study · recruiting
NCT06953908 — The Copenhagen Gender Identity Cohort · recruiting

Other Universitätsklinikum Hamburg-Eppendorf trials

Trials by the same sponsor.

NCT07443384 — Complications Associated With Radiofrequency Microneedling in Dermatology: a Delphi Consensus · not yet recruiting
NCT07385092 — Continuous Vital Sign Monitoring Versus Routine Spot-checks in Patients After Non-cardiac Surgery · NA · recruiting
NCT07009522 — Hamburg Emotion Awareness and Regulation Group Training for Autistic Adolescents (HEART) · EARLY_PHASE1 · not yet recruiting
NCT07115394 — EEG Measurements to Capture DBS-induced Electric Potentials · recruiting
NCT06955884 — Patient Experience of Transoral Versus Transnasal Awake Tracheal Intubation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04028219 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universitätsklinikum Hamburg-Eppendorf
Last refreshed: 8 November 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04028219.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing